EverSource Wealth Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
EverSource Wealth Advisors's CLB Position: Q2 2026 in Review
EverSource Wealth Advisors reduced its Core Laboratories (CLB) stake by 80% in Q2 2026, selling an estimated $7.32K and leaving 129 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3831.
EverSource Wealth Advisors first reported a position in CLB in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.3K in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- EverSource Wealth Advisors held 129 shares of Core Laboratories worth $1.5K as of Q2 2026.
- EverSource Wealth Advisors sold 513 Core Laboratories shares in Q2 2026, an estimated $7.32K.
- Core Laboratories made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3831 holding.
- EverSource Wealth Advisors first reported a position in Core Laboratories in Q4 2021 and has held it in 19 quarters since.
- EverSource Wealth Advisors's Core Laboratories position peaked at $14.3K in Q4 2025.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.